Since we barely detected CD63-positive sEVs in supernatants of our glioblastoma cells in preliminary experiments, we focused our examinations on the expression of CD9 and CD81 in human glioma tissues using accessible online data and in the different glioblastoma cells. This evidence concerns the gene CD9 and central nervous system cancer.